This year’s data draw has been completed – thanks for the outstanding commitment of everyone involved!
At the same time, please note that the questionnaire version has been updated; the current version is now V9.2.
Our 8th International Anaphylaxis Conference will take place on March 28th and 29th. We look forward to an interactive exchange!
Status: Tuesday, 04. March 2025
14183 completed cases
| Male patients | 6643 | 47% |
| Female patients | 7540 | 53% |
| Children and youths | 3371 | 24% |
| Adults | 10812 | 76% |
completed cases per country:
| Germany | 10470 | 74% |
| Austria | 1182 | 8% |
| Switzerland | 2531 | 18% |
2631 completed cases
| Male patients | 1415 | 54% |
| Female patients | 1216 | 46% |
| Children and youths | 1082 | 41% |
| Adults | 1549 | 59% |
3524 completed cases
| Male patients | 1968 | 56% |
| Female patients | 1556 | 44% |
| Children and youths | 1403 | 40% |
| Adults | 2121 | 60% |
completed cases per country:
| Brazil | 263 | 7% |
| Bulgaria | 255 | 7% |
| Greece | 423 | 12% |
| Ireland | 240 | 7% |
| Italy | 961 | 27% |
| Poland | 550 | 16% |
| Spain | 663 | 19% |
| Romania | 78 | 2% |
| Netherlands | 64 | 2% |
| Croatia | 25 | 1% |
347 completed cases
| Male patients | 189 | 54% |
| Female patients | 158 | 46% |
| Children and youths | 305 | 88% |
| Adults | 42 | 12% |
